Cargando…

Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine

BACKGROUND: MicroRNAs play an ess ential role in colorectal cancer development and progression. Aberrant miR-409-3p expression has been reported in several cancers. However, the clinical significance and functions of miR-409-3p in human CRC were not entirely clear. METHODS: miR-409-3p expression lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mulin, Xu, Aman, Yuan, Xiao, Zhang, Qiao, Fang, Taotao, Wang, Wenbin, Li, Chenglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472171/
https://www.ncbi.nlm.nih.gov/pubmed/26084278
http://dx.doi.org/10.1186/s12967-015-0533-x
_version_ 1782377014078996480
author Liu, Mulin
Xu, Aman
Yuan, Xiao
Zhang, Qiao
Fang, Taotao
Wang, Wenbin
Li, Chenglong
author_facet Liu, Mulin
Xu, Aman
Yuan, Xiao
Zhang, Qiao
Fang, Taotao
Wang, Wenbin
Li, Chenglong
author_sort Liu, Mulin
collection PubMed
description BACKGROUND: MicroRNAs play an ess ential role in colorectal cancer development and progression. Aberrant miR-409-3p expression has been reported in several cancers. However, the clinical significance and functions of miR-409-3p in human CRC were not entirely clear. METHODS: miR-409-3p expression levels were determined in 45 pairs of primary CRC and their corresponding adjacent non-tumor tissues by qPCR. The effects of ectopic expression of miR-409-3p on CRC cells proliferation, wound healing, metastasis were investigated by CCK-8, transwell assay and peritoneal spreading nude mice model. RESULTS: Statistical analysis of clinical cases revealed that low miR-409-3p expression had inclinations towards lager tumor size and local invasion. Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the abilities of proliferation, wound healing, metastasis and invasion in CRC cells. Notably, we found the NLK could be a potential target of miR-409-3p. CONCLUSION: Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development and metastasis of CRC, suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target of the treatment of CRC.
format Online
Article
Text
id pubmed-4472171
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44721712015-06-19 Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine Liu, Mulin Xu, Aman Yuan, Xiao Zhang, Qiao Fang, Taotao Wang, Wenbin Li, Chenglong J Transl Med Research BACKGROUND: MicroRNAs play an ess ential role in colorectal cancer development and progression. Aberrant miR-409-3p expression has been reported in several cancers. However, the clinical significance and functions of miR-409-3p in human CRC were not entirely clear. METHODS: miR-409-3p expression levels were determined in 45 pairs of primary CRC and their corresponding adjacent non-tumor tissues by qPCR. The effects of ectopic expression of miR-409-3p on CRC cells proliferation, wound healing, metastasis were investigated by CCK-8, transwell assay and peritoneal spreading nude mice model. RESULTS: Statistical analysis of clinical cases revealed that low miR-409-3p expression had inclinations towards lager tumor size and local invasion. Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the abilities of proliferation, wound healing, metastasis and invasion in CRC cells. Notably, we found the NLK could be a potential target of miR-409-3p. CONCLUSION: Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development and metastasis of CRC, suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target of the treatment of CRC. BioMed Central 2015-06-18 /pmc/articles/PMC4472171/ /pubmed/26084278 http://dx.doi.org/10.1186/s12967-015-0533-x Text en © Liu et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Mulin
Xu, Aman
Yuan, Xiao
Zhang, Qiao
Fang, Taotao
Wang, Wenbin
Li, Chenglong
Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
title Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
title_full Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
title_fullStr Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
title_full_unstemmed Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
title_short Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
title_sort downregulation of microrna-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472171/
https://www.ncbi.nlm.nih.gov/pubmed/26084278
http://dx.doi.org/10.1186/s12967-015-0533-x
work_keys_str_mv AT liumulin downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine
AT xuaman downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine
AT yuanxiao downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine
AT zhangqiao downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine
AT fangtaotao downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine
AT wangwenbin downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine
AT lichenglong downregulationofmicrorna4093ppromotesaggressivenessandmetastasisincolorectalcanceranindicationforpersonalizedmedicine